Finance

Beta
Lists
VLA:VIE
Valneva SE
€2.38
-0.59%
(-0.014) 1D
Jun 3, 5:36:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for VLA...
Open
€2.37
High
€2.39
Low
€2.36
Mkt. cap
446.02M
Avg. vol.
9.66K
Volume
3.11K
52-wk high
€5.30
52-wk low
€2.14
EPS
-€0.79
Shares outstanding
90.92M
No. of employees
674
Open
€2.37
High
€2.39
Low
€2.36
Mkt. cap
446.02M
Avg. vol.
9.66K
Volume
3.11K
52-wk high
€5.30
52-wk low
€2.14
EPS
-€0.79
Shares outstanding
90.92M
No. of employees
674
News stories
From sources across the web
Profile
Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
About Valneva SE
CEOThomas Lingelbach
Employees674
Founded2013
Headquarters-
SectorBiotechnology
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
48.33M
29.41M
47.69M
30.90M
Cost of goods sold
41.61M
51.19M
61.64M
26.18M
Cost of revenue
41.61M
51.19M
61.64M
26.18M
Research and development expenses
-
-
-
15.22M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.99M
18.80M
16.54M
15.14M
Operating expense
17.36M
15.56M
13.73M
28.42M
Total operating expenses
58.97M
66.76M
75.37M
54.60M
Operating income
-10.64M
-37.35M
-27.68M
-23.70M
Other non operating income
-1.00K
-
-
526.00K
EBT including unusual items
-11.81M
-43.47M
-51.08M
-31.25M
EBT excluding unusual items
-11.58M
-43.70M
-51.49M
-31.25M
Income tax expense
-223.00K
882.00K
-1.06M
824.00K
Effective tax rate
1.89%
-2.03%
2.08%
-2.64%
Other operating expenses
-2.62M
-3.24M
-2.81M
-1.93M
Net income
-11.59M
-44.36M
-50.02M
-32.07M
Net profit margin
-23.97%
-150.82%
-104.89%
-103.78%
Earnings per share
-
-
-
-0.18
Interest and investment income
554.00K
808.00K
-
-
Interest expense
-5.61M
-5.67M
-24.71M
-5.09M
Net interest expenses
-5.05M
-4.86M
-24.71M
-5.09M
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.23M
-31.96M
-26.96M
-19.46M
Gain or loss from assets sale
230.00K
-230.00K
432.00K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more